| 纯度 | >90%SDS-PAGE. |
| 种属 | Human |
| 靶点 | NTMT1 |
| Uniprot No | Q9BV86 |
| 内毒素 | < 0.01EU/μg |
| 表达宿主 | E.coli |
| 表达区间 | 2-223aa |
| 氨基酸序列 | TSEVIEDEKQFYSKAKTYWKQIPPTVDGMLGGYGHISSIDINSSRKFLQRFLREGPNKTGTSCALDCGAGIGRITKRLLLPLFREVDMVDITEDFLVQAKTYLGEEGKRVRNYFCCGLQDFTPEPDSYDVIWIQWVIGHLTDQHLAEFLRRCKGSLRPNGIIVIKDNMAQEGVILDDVDSSVCRDLDVVRRIICSAGLSLLAEERQENLPDEIYHVYSFALR |
| 预测分子量 | 52.7 kDa |
| 蛋白标签 | His tag N-Terminus |
| 缓冲液 | PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300. |
| 稳定性 & 储存条件 | Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months. |
| 复溶 | Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles. |
以下是关于NTMT1重组蛋白的3篇参考文献及其摘要概括：
1. **文献名称**: "Structural basis of substrate recognition by human N-terminal methyltransferase NTMT1"
**作者**: Dong C, et al.
**摘要**: 该研究通过X射线晶体学解析了人源NTMT1与底物复合物的三维结构，揭示了其识别底物N端特定氨基酸序列(如RG序列)的分子机制，并阐明了甲基转移反应的催化机理。
2. **文献名称**: "NTMT1-mediated N-terminal methylation of proteins regulates chromosome alignment and mitotic progression"
**作者**: Doran CJ, et al.
**摘要**: 本文发现NTMT1通过甲基化修饰RCC1(染色体浓缩调节因子1)的N端，调控其在有丝分裂中的功能，证明NTMT1重组蛋白的酶活缺失会导致染色体分离异常和细胞周期停滞。
3. **文献名称**: "Substrate specificity and kinetic mechanism of mammalian N-terminal methyltransferase 1"
**作者**: Tooley CE, et al.
**摘要**: 该研究利用重组表达的NTMT1蛋白进行体外酶活分析，系统表征了其对不同N端序列底物的选择性及动力学参数，发现其对RG/S/T-P序列具有高度特异性。
*注：以上文献为代表性研究，实际引用时需核对具体发表年份及期刊卷期。如需补充更多研究，可进一步检索近年关于NTMT1酶学特性或疾病关联的论文。*
**Background of NTMT1 Recombinant Protein**
N-terminal methyltransferase 1 (NTMT1), also known as METTL11A or NRMT1. is a conserved eukaryotic enzyme responsible for catalyzing the methylation of proteins at their N-terminal α-amino groups. This post-translational modification plays a critical role in regulating protein stability, localization, and interaction networks. NTMT1 specifically recognizes substrates with an N-terminal [X-P-K/R] consensus motif, transferring methyl groups from S-adenosylmethionine (SAM) to the terminal amine. Known substrates include DNA repair proteins (e.g., RCC1. CENP-A), transcriptional regulators, and chromatin-associated factors, linking NTMT1 to essential cellular processes like genome maintenance, cell cycle progression, and epigenetic regulation.
Recombinant NTMT1 protein is produced via heterologous expression systems (e.g., *E. coli* or mammalian cells) to study its enzymatic activity, substrate specificity, and structural properties. Structural studies reveal a conserved Rossmann-fold domain for SAM binding and a flexible loop critical for substrate recognition. Dysregulation of NTMT1 has been implicated in diseases, including cancers and neurodegenerative disorders, highlighting its therapeutic potential. For instance, NTMT1 overexpression correlates with tumor progression, while its loss disrupts mitotic fidelity.
Researchers utilize recombinant NTMT1 to screen inhibitors, map methylation sites via mass spectrometry, and engineer methylated proteins for functional studies. Its applications extend to drug discovery, particularly in targeting methylation-dependent pathways. Additionally, NTMT1’s role in aging and DNA damage response remains an active area of investigation. The development of high-purity, active recombinant NTMT1 has thus become pivotal for advancing mechanistic and translational studies in epigenetics and beyond.
×
